3rd Quarter - Report
BIOCOM for BIOCOM
Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Advocated for 12 years of data exclusivities for biologics in the TPP agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Taxation/Internal Revenue Code TAX
Expressed support for a repeal of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Raised concerns with H.R.9, the Innovation Act, and asked Members to oppose the bill. Advocated for a Hatch-Waxman/BPCIA exemption from IPR proceedings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Asked to vote for HR6, the 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Budget/Appropriations BUD
Asked for increased NIH funding. Asked Congress to pass legislation to fund the federal government in FY2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.